[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

LAMEA Continuous Glucose Monitoring Device Market By Component (Sensors, Transmitters, and Receivers) By End User (Hospitals, Homecare Settings and Other End Users) By Country, Industry Analysis and Forecast, 2020 - 2026

April 2020 | 81 pages | ID: LE55EFBEFD64EN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Latin America, Middle East and Africa Continuous Glucose Monitoring Device Market would witness market growth of 13.4% CAGR during the forecast period (2020-2026).
The CGM displays a glucose trend graph and direction arrows that enable people with diabetes to predict rising glucose levels and lows, thus alerting the user at distracted periods such as playing, sleeping or exercising. The demand for CGM products is projected to gain significant momentum due to collaborations between endocrinologists, credentialed diabetes educators, and diabetes prevention stakeholder organizations.
Growing cases of diabetes have accelerated the market, along with the rising use of continuous glucose monitoring (CGM) devices. CGM devices are minimally invasive and provide a simple and reliable approach to diabetes treatment. They can also track dramatic changes in levels of blood glucose, thereby avoiding hypoglycemic disorders.
Through the assistance of a sensor, these instruments enable the analysis of blood glucose levels at different time intervals. Respective readings fed in via a wireless network to a diabetes treatment software allow patients to better understand the condition, thereby allowing them to treat it more effectively.The main risk factors associated with diabetes problems are smoking, obesity, physical inactivity, and high blood pressure and elevated cholesterol.
Based on Component, the market is segmented into Sensors, Transmitters, and Receivers. Based on End User, the market is segmented into Hospitals, Homecare Settings and Other End Users. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, DexCom, Inc., Ypsomed AG, Senseonics Holdings, Inc., GlySens, Incorporated, A. Menarini Diagnostics Ltd. (The Menarini Group), Echo Therapeutics, Inc., Johnson and Johnson

Scope of the Study

Market Segmentation:

By Component
  • Sensors
  • Transmitters and
  • Receivers
By End User
  • Hospitals
  • Homecare Settings and
  • Other End Users
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Abbott Laboratories
  • Medtronic PLC
  • F. Hoffmann-La Roche Ltd.
      • Novo Nordisk A/S
  • DexCom, Inc.
  • Ypsomed AG
  • Senseonics Holdings, Inc.
  • GlySens, Incorporated
  • A. Menarini Diagnostics Ltd. (The Menarini Group)
      • Echo Therapeutics, Inc.
  • Johnson and Johnson
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 LAMEA Continuous Glucose Monitoring Device Market, by Component
  1.4.2 LAMEA Continuous Glucose Monitoring Device Market, by End User
  1.4.3 LAMEA Continuous Glucose Monitoring Device Market, by Country
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT

3.1 LAMEA Sensors Market by Country
3.2 LAMEA Transmitters Market by Country
3.3 LAMEA Receivers Market by Country

CHAPTER 4. LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER

4.1 LAMEA Hospitals Continuous Glucose Monitoring Device Market by Country
4.2 LAMEA Homecare Settings Market by Country
4.3 LAMEA Other End Users Market by Country

CHAPTER 5. LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY

5.1 Brazil Continuous Glucose Monitoring Device Market
  5.1.1 Brazil Continuous Glucose Monitoring Device Market by Component
  5.1.2 Brazil Continuous Glucose Monitoring Device Market by End-user
5.2 Argentina Continuous Glucose Monitoring Device Market
  5.2.1 Argentina Continuous Glucose Monitoring Device Market by Component
  5.2.2 Argentina Continuous Glucose Monitoring Device Market by End-user
5.3 UAE Continuous Glucose Monitoring Device Market
  5.3.1 UAE Continuous Glucose Monitoring Device Market by Component
  5.3.2 UAE Continuous Glucose Monitoring Device Market by End-user
5.4 Saudi Arabia Continuous Glucose Monitoring Device Market
  5.4.1 Saudi Arabia Continuous Glucose Monitoring Device Market by Component
  5.4.2 Saudi Arabia Continuous Glucose Monitoring Device Market by End-user
5.5 South Africa Continuous Glucose Monitoring Device Market
  5.5.1 South Africa Continuous Glucose Monitoring Device Market by Component
  5.5.2 South Africa Continuous Glucose Monitoring Device Market by End-user
5.6 Nigeria Continuous Glucose Monitoring Device Market
  5.6.1 Nigeria Continuous Glucose Monitoring Device Market by Component
  5.6.2 Nigeria Continuous Glucose Monitoring Device Market by End-user
5.7 Rest of LAMEA Continuous Glucose Monitoring Device Market
  5.7.1 Rest of LAMEA Continuous Glucose Monitoring Device Market by Component
  5.7.2 Rest of LAMEA Continuous Glucose Monitoring Device Market by End-user

CHAPTER 6. COMPANY PROFILES

6.1 Abbott Laboratories
  6.1.1 Company Overview
  6.1.2 Financial Analysis
  6.1.3 Segmental and Regional Analysis
  6.1.4 Research & Development Expense
  6.1.5 Recent strategies and developments:
    6.1.5.1 Partnerships, Collaborations, and Agreements:
    6.1.5.2 Product Launches and Product Expansions:
6.2 Medtronic PLC
  6.2.1 Company overview
  6.2.2 Financial Analysis
  6.2.3 Segmental and Regional Analysis
  6.2.4 Research & Development Expenses
  6.2.5 Recent strategies and developments:
    6.2.5.1 Partnerships, Collaborations, and Agreements:
    6.2.5.2 Acquisition and Mergers:
    6.2.5.3 Approvals:
6.3 F. Hoffmann-La Roche Ltd.
  6.3.1 Company Overview
  6.3.2 Financial Analysis
  6.3.3 Segmental and Regional Analysis
  6.3.4 Research & Development Expense
  6.3.5 Recent strategies and developments:
    6.3.5.1 Partnerships, Collaborations, and Agreements:
    6.3.5.2 Acquisition and Mergers:
6.4 Novo Nordisk A/S
  6.4.1 Company Overview
  6.4.2 Financial Analysis
  6.4.3 Segmental & Regional Analysis
  6.4.4 Research & Development Expenses
  6.4.5 Recent strategies and developments:
    6.4.5.1 Partnerships, Collaborations, and Agreements:
    6.4.5.2 Acquisition and Mergers:
6.5 DexCom, Inc.
  6.5.1 Company Overview
  6.5.2 Financial Analysis
  6.5.3 Regional Analysis
  6.5.4 Research & Development Expenses
  6.5.5 Recent strategies and developments:
    6.5.5.1 Partnerships, Collaborations, and Agreements:
    6.5.5.2 Approvals:
6.6 Ypsomed AG
  6.6.1 Company Overview
  6.6.2 Financial Analysis
  6.6.3 Segmental and Regional Analysis
  6.6.4 Research & Development Expense
  6.6.5 Recent strategies and developments:
    6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Senseonics Holdings, Inc.
  6.7.1 Company Overview
  6.7.2 Financial Analysis
  6.7.3 Regional Analysis
  6.7.4 Research & Development Expense
  6.7.5 Recent strategies and developments:
    6.7.5.1 Partnerships, Collaborations, and Agreements:
    6.7.5.2 Approvals:
6.8 GlySens, Incorporated
  6.8.1 Company Overview
  6.8.2 Recent strategies and developments:
    6.8.2.1 Approvals:
6.9 A. Menarini Diagnostics Ltd. (The Menarini Group)
  6.9.1 Company Overview
  6.9.2 Recent strategies and developments:
    6.9.2.1 Partnerships, Collaborations, and Agreements:
6.1 Echo Therapeutics, Inc.
  6.10.1 Company Overview
6.11 Johnson and Johnson
  6.11.1 Company Overview
  6.11.2 Financial Analysis
  6.11.3 Segmental &Regional Analysis
  6.11.4 Research & Development Expenses
  6.11.5 Recent strategies and developments:
    6.11.5.1 Approvals:

LIST OF TABLES

TABLE 1 LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 4 LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 5 LAMEA SENSORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA SENSORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA TRANSMITTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA TRANSMITTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA RECEIVERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA RECEIVERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 12 LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 13 LAMEA HOSPITALS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA HOSPITALS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA HOMECARE SETTINGS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA HOMECARE SETTINGS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 22 BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 23 BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 24 BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 25 BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 26 BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 27 ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 28 ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 29 ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 30 ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 31 ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 32 ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 33 UAE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 34 UAE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 35 UAE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 36 UAE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 37 UAE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 38 UAE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 39 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 40 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 41 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 42 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 43 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 44 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 45 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 46 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 47 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 48 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 49 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 50 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 51 NIGERIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 52 NIGERIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 53 NIGERIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 54 NIGERIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 55 NIGERIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 56 NIGERIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 57 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 62 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 64 KEY INFORMATION – MEDTRONIC PLC
TABLE 65 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 66 KEY INFORMATION – NOVO NORDISK A/S
TABLE 67 KEY INFORMATION – DEXCOM, INC.
TABLE 68 KEY INFORMATION –-YPSOMED AG
TABLE 69 KEY INFORMATION – SENSEONICS HOLDINGS, INC.
TABLE 70 KEY INFORMATION – GLYSENS, INCORPORATED
TABLE 71 KEY INFORMATION – A. MENARINI DIAGNOSTICS LTD.
TABLE 72 KEY INFORMATION – ECHO THERAPEUTICS, INC.
TABLE 73 KEY INFORMATION –JOHNSON AND JOHNSON

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 4 RECENT STRATEGIES AND DEVELOPMENTS: F. HOFFMANN-LA ROCHE LTD.
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: NOVO NORDISK A/S


More Publications